Citation Impact
Citing Papers
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014
2015 Standout
Parenteral Anticoagulants
2012 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
2008 Standout
Inherited predisposition to thrombosis
1993
Transfusion practice in massively bleeding patients: time for a change?
2005
The Use of Fresh Whole Blood in Massive Transfusion
2006
Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety
2001 Standout
GRADE guidelines: 4. Rating the quality of evidence—study limitations (risk of bias)
2011 Standout
Hydrogels in Regenerative Medicine
2009 Standout
Prevention of VTE in Orthopedic Surgery Patients
2012 Standout
Perioperative Management of Antithrombotic Therapy
2012 Standout
Hemovigilance network in France: organization and analysis of immediate transfusion incident reports from 1994 to 1998
2002
Antithrombotic Therapy for VTE Disease
2016 Standout
Subcutaneous Low-Molecular-Weight Heparin Compared with Continuous Intravenous Heparin in the Treatment of Proximal-Vein Thrombosis
1992 Standout
Treatment and Prevention of Heparin-Induced Thrombocytopenia
2008 Standout
Massive Transfusion Practices Around the Globe and a Suggestion for a Common Massive Transfusion Protocol
2006
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Grading Strength of Recommendations and Quality of Evidence in Clinical Guidelines
2006 Standout
Use of a chitosan‐based hemostatic dressing in laparoscopic partial nephrectomy
2007
Reliability Study of the Leg-O-Meter, an Improved Tape Measure Device, in Patients with Chronic Venous Insufficiency of the Leg
1998
Prevention of VTE in Nonsurgical Patients
2012 Standout
Mutation in the Gene Coding for Coagulation Factor V and the Risk of Myocardial Infarction, Stroke, and Venous Thrombosis in Apparently Healthy Men
1995 Standout
Increased Plasma and Platelet to Red Blood Cell Ratios Improves Outcome in 466 Massively Transfused Civilian Trauma Patients
2008 Standout
Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study
2008 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
Biodegradable polymeric nanoparticles based drug delivery systems
2009 Standout
Heparin and Low-Molecular-Weight Heparin
2004
Prevention of VTE in Nonorthopedic Surgical Patients
2012 Standout
Renal Function After Cardiac Surgery: Adverse Effect of Furosemide
2003
Resistance to Activated Protein C as a Basis for Venous Thrombosis
1994 Standout
Prevention of Venous Thromboembolism
2004 Standout
How were new medicines discovered?
2011 Standout
Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer
2003 Standout
Guidelines on the management of massive blood loss
2006
Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated Heparin
1995 Standout
Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty
2008 Standout
Prevention of Venous Thromboembolism
2008 Standout
Dose adjusted heparin treatment of deep venous thrombosis: a comparison of unfractionated and low molecular weight heparin
1990
A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease
1997 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
2001 Standout
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
2011 Standout
Review of Current Blood Transfusions Strategies in a Mature Level I Trauma Center: Were We Wrong for the Last 60 Years?
2008
Hemorrhagic Complications of Anticoagulant Treatment
2001 Standout
Sulfation of silk fibroin by chlorosulfonic acid and the anticoagulant activity
2003
Outpatient treatment of deep vein thrombosis: translating clinical trials into practice
1999
New ideas in biomaterials science—a path to engineered biomaterials
1993
The engineering of biomaterials exhibiting recognition and specificity
1996
Preparation and characterization of protein C-loaded PLA nanoparticles
1999
Composition of the protein layers adsorbed from blood or plasma to solid surfaces: A perspective
1985
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Low Molecular Weight Heparin versus Warfarin in the Prevention of Recurrences after Deep Vein Thrombosis
1994
Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1)
2013 Standout
Plasminogen Activators, Tissue Degradation, and Cancer
1985 Standout
Low Molecular Weight Versus Standard Heparin for Prevention of Venous Thromboembolism After Major Abdominal Surgery
1993
Sulfation of silk fibroin by sulfuric acid and anticoagulant activity
2003
Massive blood transfusion for trauma
2005
A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
1996 Standout
Regulation of plasminogen activator secretion in mouse peritoneal macrophages
1979
Chitin and chitosan polymers: Chemistry, solubility and fiber formation
2009 Standout
Mineralization of Synthetic Polymer Scaffolds: A Bottom-Up Approach for the Development of Artificial Bone
2005 StandoutNobel
Low molecular weight heparin
1992
Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention
2009 Standout
Self-Assembled Organic Monolayers: Model Systems for Studying Adsorption of Proteins at Aurfaces
1991 StandoutScience
The Biological Basis for Cardiac Repair After Myocardial Infarction
2016 Standout
Investigation of Chronic Venous Insufficiency
2000 Standout
Safety of Low-Molecular-Weight Heparin in Pregnancy: A Systematic Review
1999
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Low-Molecular-Weight Heparins
1997 Standout
Third-Generation Biomedical Materials
2002 StandoutScience
Familial Dysfibrinogenemia and Thrombophilia
1995
Development and validation of a predictive model for chemotherapy-associated thrombosis
2008 Standout
Treatment With OPN-305, a Humanized Anti–Toll-Like Receptor-2 Antibody, Reduces Myocardial Ischemia/Reperfusion Injury in Pigs
2012
Venous thrombosis: a multicausal disease
1999 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
A New Approach to Mineralization of Biocompatible Hydrogel Scaffolds: An Efficient Process toward 3-Dimensional Bonelike Composites
2003 StandoutNobel
Evidence-Based Surgical Care and the Evolution of Fast-Track Surgery
2008 Standout
Low molecular weight heparin
1992
Polymeric materials based on silk proteins
2008 Standout
Works of Marc Samama being referenced
Platelet functions and haemostasis parameters in pigs: Absence of side effects of a procedure of general anaesthesia
1996
Massive transfusion and coagulopathy: pathophysiology and implications for clinical management
2004
Reduction in Requirements for Allogeneic Blood Products: Nonpharmacologic Methods
1996
Double-Blind Trial of the Efficacy of Troxerutin in Chronic Venous Insufficiency
1994
New heparin-like insoluble materials: Part I
1979
New heparin-like insoluble materials: Part II
1979
[Constitutional protein C deficiency in 57 patients from 22 non-related families].
1986
Applying risk assessment models in general surgery: effective risk stratification.
1999
[Plasminogen determination, using a chromogenic tripeptidic substrate (author's transl)].
1976
[Protein C and its clinical implications].
1985
Pharmacokinetics of low molecular weight heparins.
1988
Episodes of increased fibronectin level observed in a patient suffering from recurrent thrombosis related to congenital hypodysfibrinogenaemia (fibrinogen Malmoe)
1985